mTOR inhibitors (ARIAD)

N/A

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NamemTOR inhibitors (ARIAD)
Drug Alias Namebone tumor therapeutics (ARIAD)AP-23675AP-23841AP-24170
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsBone metastasesBone Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAriad Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAriad Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsBone metastasesBone Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A